Esther M. Yoo, Ph.D. - Publications

Affiliations: 
2000 University of California, Los Angeles, Los Angeles, CA 
Area:
Molecular Biology, Immunology

12 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2016 Vasuthasawat A, Yoo EM, Trinh KR, Lichtenstein A, Timmerman JM, Morrison SL. Targeted immunotherapy using anti-CD138-interferon α fusion proteins and bortezomib results in synergistic protection against multiple myeloma. Mabs. 0. PMID 27362935 DOI: 10.1080/19420862.2016.1207030  0.541
2015 Yoo EM, Trinh KR, Tran D, Vasuthasawat A, Zhang J, Hoang B, Lichtenstein A, Morrison SL. Anti-CD138-targeted interferon is a potent therapeutic against multiple myeloma. Journal of Interferon & Cytokine Research : the Official Journal of the International Society For Interferon and Cytokine Research. 35: 281-91. PMID 25353626 DOI: 10.1089/Jir.2014.0125  0.55
2014 Morrison SL, Yoo EM. Genetically Engineered Antibody Molecules Reference Module in Biomedical Research. DOI: 10.1016/B978-0-12-801238-3.00129-X  0.493
2012 Yoo E, Vasuthasawat A, Tran D, Lichtenstein A, Morrison S. Anti-CD138-IFNα Fusion Proteins Are Effective in Treating Multiple Myeloma Blood. 120: 939-939. DOI: 10.1182/Blood.V120.21.939.939  0.551
2011 Yoo EM, Trinh KR, Lim H, Wims LA, Morrison SL. Characterization of IgA and IgM binding and internalization by surface-expressed human Fcα/μ receptor. Molecular Immunology. 48: 1818-26. PMID 21632111 DOI: 10.1016/J.Molimm.2011.05.011  0.555
2010 Yoo EM, Yu LJ, Wims LA, Goldberg D, Morrison SL. Differences in N-glycan structures found on recombinant IgA1 and IgA2 produced in murine myeloma and CHO cell lines. Mabs. 2: 320-34. PMID 20431350 DOI: 10.4161/Mabs.2.3.11802  0.607
2007 Beenhouwer DO, Yoo EM, Lai CW, Rocha MA, Morrison SL. Human immunoglobulin G2 (IgG2) and IgG4, but not IgG1 or IgG3, protect mice against Cryptococcus neoformans infection. Infection and Immunity. 75: 1424-35. PMID 17220317 DOI: 10.1128/Iai.01161-06  0.603
2007 Yoo EM, Chintalacharuvu KR, Morrison SL. Recombinant IgA antibodies Mucosal Immune Defense: Immunoglobulin A. 390-415. DOI: 10.1007/978-0-387-72232-0_15  0.572
2005 Yoo EM, Morrison SL. IgA: an immune glycoprotein. Clinical Immunology (Orlando, Fla.). 116: 3-10. PMID 15925826 DOI: 10.1016/J.Clim.2005.03.010  0.557
2003 Yoo EM, Wims LA, Chan LA, Morrison SL. Human IgG2 can form covalent dimers. Journal of Immunology (Baltimore, Md. : 1950). 170: 3134-8. PMID 12626570 DOI: 10.4049/Jimmunol.170.6.3134  0.617
2002 Yoo EM, Chintalacharuvu KR, Penichet ML, Morrison SL. Myeloma expression systems. Journal of Immunological Methods. 261: 1-20. PMID 11861062 DOI: 10.1016/S0022-1759(01)00559-2  0.639
1999 Yoo EM, Coloma MJ, Trinh KR, Nguyen TQ, Vuong LU, Morrison SL, Chintalacharuvu KR. Structural requirements for polymeric immunoglobulin assembly and association with J chain. The Journal of Biological Chemistry. 274: 33771-7. PMID 10559270 DOI: 10.1074/Jbc.274.47.33771  0.483
Show low-probability matches.